Drugs · acquisition-cost intelligence
Clofenax
Diclofenac· ingredient diclofenacAcetic acid derivatives and related substances· DICLOFENAC SODIUM 16.05 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.12486
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other diclofenac products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| Diclofenac Sodium Delayed Release | $0.06665 | −$0.05820 |
| Diclofenac DR | $0.06665 | −$0.05820 |
| Aleve Arthritis Pain Gel | $0.08776 | −$0.03710 |
| Diclofenac Potassium | $0.09863 | −$0.02620 |
| Diclofenac Sodium | $0.36949 | +$0.24460 |
| Diclofenac Sodium | $0.39681 | +$0.27200 |
| Diclofenac Sodium Delayed Release | $0.72051 | +$0.59570 |
| Diclofenac Sodium ER | $0.73145 | +$0.60660 |
Medicare Part D coverage · CY2026
On 323 plan formularies · typical tier 2
Prior auth 27% · Step therapy 0% · Quantity limit 66% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.